MYLAN 8008 MYLAN 8008 (Divalproex Sodium Delayed-Release (Sprinkle) 125 mg)

Pill with imprint MYLAN 8008 MYLAN 8008 is Purple / White, Capsule-shape and has been identified as Divalproex Sodium Delayed-Release (Sprinkle) 125 mg. It is supplied by Mylan Pharmaceuticals Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 8008 MYLAN 8008

Divalproex Sodium Delayed-Release (Sprinkle)

Imprint

MYLAN 8008 MYLAN 8008

Strength

125 mg

Color

Purple / White

Shape

Capsule-shape

Availability

Prescription only

Drug Class

Fatty acid derivative anticonvulsants

Pregnancy Category

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine

CSA Schedule

Not a controlled drug

Labeler / Supplier

Mylan Pharmaceuticals Inc.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00378-8008	Mylan Pharmaceuticals Inc.
51079-0765	UDL Laboratories Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer